Connealy Pamela Yanchik insider trades: Pyxis Oncology (PYXS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Connealy reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | PYXS | ↑ Buy | 83,400 | $1.96 | $163K | By Spouse | Nov 27, 2024 (1d) |
| Nov 26, 2024 | PYXS | ↑ Buy | 5,450 | $2.00 | $11K | By Trust | Nov 27, 2024 (1d) |
| Sep 28, 2023 | PYXS | ↑ Buy | 8,000 | $1.87 | $15K | Direct | Sep 28, 2023 (0d) |
| Sep 27, 2023 | PYXS | ↑ Buy | 6,426 | $1.85 | $12K | Direct | Sep 27, 2023 (0d) |
| Sep 25, 2023 | PYXS | ↑ Buy | 12,000 | $1.67 | $20K | Direct | Sep 25, 2023 (0d) |
| Sep 22, 2023 | PYXS | ↑ Buy | 5,000 | $1.74 | $9K | Direct | Sep 22, 2023 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PYXS insiders
Open-market trades in the last 12 months
About Connealy Pamela Yanchik's insider trades
Connealy Pamela Yanchik is CFO & COO at Pyxis Oncology (PYXS). Since Sep 22, 2023, Connealy has reported 6 open-market purchases worth $230K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), shares withheld for taxes (1 filing), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PYXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.